A close-up of the United States flag with visible red and white stripes and white stars on a blue field. Semi-transparent hexagonal shapes overlay parts of the flag.

American Investment

Investing in America’s Future

America’s biopharmaceutical companies are expanding their manufacturing footprint and pioneering innovative research across the United States.

Amgen is driving U.S. manufacturing leadership in central Ohio.

AstraZeneca is expanding their U.S. footprint to power the future of cell therapy in Maryland.

Astellas expands manufacturing footprint in America to fuel gene therapy innovation.

Bristol Myers Squibb is expanding its U.S. manufacturing presence in Indiana to advance cancer innovation.

Gilead boosts U.S. manufacturing capacity to advance next-generation biologics.

Decades of investment in North Carolina’s biopharmaceutical industry has spurred the state’s economy, workforce development and community engagement.

$500 billion in new biopharmaceutical investment will give a $1.2 trillion boost to America’s economy

Explore how PhRMA member companies are investing in new U.S.-based manufacturing and infrastructure, creating jobs and opportunities for Americans, their families and local communities.

Member Investment News

Dark blue-green background with subtle hexagonal patterns scattered throughout. The hexagons are faint and add a textured effect to the otherwise smooth surface.

Strengthening the U.S. Economy

Source: TEConomy Partners, LLC. The Economic Impact of the U.S. Biopharmaceutical Industry: 2022 National and State Estimates. February 2024.

$1.6 trillion in economic output

Contributes substantially to the American economy, totaling more than $1.65 trillion in economic output (in 2022), which represents 3.6% of all U.S. output.

1,500+ facilities in 48 states

Operates 1,574 facilities across the country that are manufacturing innovative treatments (as of 2022).

5 million high-skilled jobs

Directly employs more than one million workers and supports an additional 3.8 million U.S. jobs indirectly.

111 million students in STEM programs

Supports 37 STEM education programs across the country, providing $180 million in financial support and reaching nearly 111 million students and 183,000 teachers.

Every day, our industry is working to bring treatments and cures to Americans.

More than 1 million employees of U.S. biopharmaceutical companies work every day to research and develop transformative treatments.

Our industry relies on a talented STEM workforce to advance innovation, which is why we’re committed to investing in the next generation of innovators through education programs at universities across the country.

We’re also working hard to develop new life-saving treatments through clinical trials across the country, with over 5,000 active clinical trial sites reaching more than 900,000 Americans.

A scientist wearing safety goggles, a face mask, and blue gloves examines a sample through a microscope in a laboratory setting.

Our industry supports America’s biopharmaceutical leadership.

Our industry’s investments and impact are driven by pro-innovation policies. Explore the biopharmaceutical clusters made possible by smart policy. 

A smooth blue gradient background transitioning from light blue at the top to darker blue at the bottom, with a soft diagonal streak of even lighter blue on the right side.

Protecting American Investment and Leadership in Biopharmaceutical Innovation

Robust, pro-innovation policies are critical to maintaining our country’s leadership and supporting patient access to transformative medicines.

Learn how we can preserve and strengthen American innovation

Our Work in Action

To maintain America’s global leadership, we need to support the next generation of innovation in medicine.

View All Case Studies
A person stands on stage beside a large screen displaying a map outline of North Carolina, labeled boldly in red with the words "NORTH CAROLINA.

Driving Economic Growth and Opportunity in North Carolina

The biopharmaceutical industry supports millions of jobs and generates significant economic growth in communities across America.

Read case study
A modern building with large glass windows and vertical brown panels, set on a landscaped street with a bench, small trees, and clear blue sky in the background.

AstraZeneca Invests in the U.S. to Power the Future of Cell Therapy

AstraZeneca’s investment in Maryland creates high-quality jobs and advances next-generation cancer treatments.

Read case study
A person wearing blue gloves and a white lab coat is handling small glass vials filled with clear liquid, arranging them on a reflective metal surface in a laboratory setting.

Vaccines Protect Health and Save Costs

Learn more about how vaccines have a long track record of protecting patient health and providing cost savings.

Read case study
Back to top

Sign up for email updates